Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Hiển thị phiên bản (1) khác

Survival has improved in bladder cancer but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed survival in urothelial cancer (UC, of which vast majority are bladder cancers) in Finland and Sweden over a 50-year period...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg, Otto Hemminki
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Public Library of Science (PLoS) 2022-01-01
Loạt:	PLoS ONE
Truy cập trực tuyến:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261124&type=printable

Những quyển sách tương tự

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
Bằng: Kari Hemminki, et al.
Được phát hành: (2022-01-01)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
Bằng: Kari Hemminki, et al.
Được phát hành: (2021-01-01)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
Bằng: Akseli Hemminki, et al.
Được phát hành: (2021-10-01)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
Bằng: Kari Hemminki, et al.
Được phát hành: (2021-05-01)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
Bằng: Kari Hemminki, et al.
Được phát hành: (2022-04-01)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
Bằng: Anni Koskinen, et al.
Được phát hành: (2022-01-01)

Bladder and upper urinary tract cancers as first and second primary cancers
Bằng: Guoqiao Zheng, et al.
Được phát hành: (2021-12-01)

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
Bằng: Kari Hemminki, et al.
Được phát hành: (2024-04-01)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
Bằng: Filip Tichanek, et al.
Được phát hành: (2023-01-01)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
Bằng: Kari Hemminki, et al.
Được phát hành: (2023-05-01)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
Bằng: Kari Hemminki, et al.
Được phát hành: (2022-12-01)

Conditional survival in breast cancer up to 10 years in the Nordic countries
Bằng: Frantisek Zitricky, et al.
Được phát hành: (2023-09-01)

Survival trends in hematological malignancies in the Nordic countries through 50 years
Bằng: Kari Hemminki, et al.
Được phát hành: (2022-11-01)

Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients
Bằng: Kari Hemminki, et al.
Được phát hành: (2024-08-01)

High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancers
Bằng: Kari Hemminki, et al.
Được phát hành: (2025-02-01)

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century
Bằng: Frantisek Zitricky, et al.
Được phát hành: (2024-01-01)

Age-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancers
Bằng: Kari Hemminki, et al.
Được phát hành: (2025-02-01)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
Bằng: Kari Hemminki, et al.
Được phát hành: (2021-08-01)

Incidence and survival in non-hereditary amyloidosis in Sweden
Bằng: Hemminki Kari, et al.
Được phát hành: (2012-11-01)

Familial risks in and between stone diseases: sialolithiasis, urolithiasis and cholelithiasis in the population of Sweden
Bằng: Kari Hemminki, et al.
Được phát hành: (2018-07-01)

Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor
Bằng: Guoqiao Zheng, et al.
Được phát hành: (2020-11-01)

Epidemiology of Amyloidosis and Genetic Pathways to Diagnosis and Typing
Bằng: Kari Hemminki, et al.
Được phát hành: (2021-07-01)

Family history of any cancer for childhood leukemia patients in Sweden
Bằng: Xinjun Li, et al.
Được phát hành: (2021-08-01)

Survival in Thyroid Cancer in Sweden From 1999 To 2018
Bằng: Zitricky F, et al.
Được phát hành: (2024-10-01)

Second cancers and causes of death in patients with testicular cancer in Sweden.
Bằng: Luyao Zhang, et al.
Được phát hành: (2019-01-01)

Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
Bằng: Riihimäki Matias, et al.
Được phát hành: (2013-01-01)

Prostate cancer survivors: Risk and mortality in second primary cancers
Bằng: Subhayan Chattopadhyay, et al.
Được phát hành: (2018-11-01)

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
Bằng: Kari Hemminki, et al.
Được phát hành: (2017-08-01)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
Bằng: Tichanek F, et al.
Được phát hành: (2023-05-01)

Survival in common cancers defined by risk and survival of family members
Bằng: Jianguang Ji, et al.
Được phát hành: (2011-10-01)

Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden
Bằng: Hauke Thomsen, et al.
Được phát hành: (2020-01-01)

Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
Bằng: Guoqiao Zheng, et al.
Được phát hành: (2021-02-01)

Familial Associations of Colorectal Cancer with Other Cancers
Bằng: Hongyao Yu, et al.
Được phát hành: (2017-07-01)

Oncolytic viruses for cancer immunotherapy
Bằng: Otto Hemminki, et al.
Được phát hành: (2020-06-01)

The 'common disease-common variant' hypothesis and familial risks.
Bằng: Kari Hemminki, et al.
Được phát hành: (2008-01-01)

Oncolytic Immunotherapy: Where Are We Clinically?
Bằng: Akseli Hemminki
Được phát hành: (2014-01-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
Bằng: Akseli Hemminki
Được phát hành: (2012-08-01)

TILT Biotherapeutics
Bằng: Akseli Hemminki
Được phát hành: (2017-05-01)

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not
Bằng: Otto Hemminki, et al.
Được phát hành: (2020-12-01)

Are population level familial risks and germline genetics meeting each other?
Bằng: Kari Hemminki, et al.
Được phát hành: (2023-03-01)